539 related articles for article (PubMed ID: 17728232)
1. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
[TBL] [Abstract][Full Text] [Related]
2. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.
Schneidewind A; Brockman MA; Yang R; Adam RI; Li B; Le Gall S; Rinaldo CR; Craggs SL; Allgaier RL; Power KA; Kuntzen T; Tung CS; LaBute MX; Mueller SM; Harrer T; McMichael AJ; Goulder PJ; Aiken C; Brander C; Kelleher AD; Allen TM
J Virol; 2007 Nov; 81(22):12382-93. PubMed ID: 17804494
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
4. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
[TBL] [Abstract][Full Text] [Related]
5. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
Martinez-Picado J; Prado JG; Fry EE; Pfafferott K; Leslie A; Chetty S; Thobakgale C; Honeyborne I; Crawford H; Matthews P; Pillay T; Rousseau C; Mullins JI; Brander C; Walker BD; Stuart DI; Kiepiela P; Goulder P
J Virol; 2006 Apr; 80(7):3617-23. PubMed ID: 16537629
[TBL] [Abstract][Full Text] [Related]
6. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
[TBL] [Abstract][Full Text] [Related]
7. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
Tsai MC; Singh S; Adland E; Goulder P
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
[TBL] [Abstract][Full Text] [Related]
8. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
[TBL] [Abstract][Full Text] [Related]
9. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
10. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
11. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
Gijsbers EF; Feenstra KA; van Nuenen AC; Navis M; Heringa J; Schuitemaker H; Kootstra NA
PLoS One; 2013; 8(12):e81235. PubMed ID: 24339913
[TBL] [Abstract][Full Text] [Related]
13. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P
Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323
[TBL] [Abstract][Full Text] [Related]
14. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
[TBL] [Abstract][Full Text] [Related]
15. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein.
Boutwell CL; Rowley CF; Essex M
J Virol; 2009 Mar; 83(6):2460-8. PubMed ID: 19109381
[TBL] [Abstract][Full Text] [Related]
16. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
[TBL] [Abstract][Full Text] [Related]
17. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
[TBL] [Abstract][Full Text] [Related]
18. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
[TBL] [Abstract][Full Text] [Related]
19. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
[TBL] [Abstract][Full Text] [Related]
20. Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant.
Schneidewind A; Tang Y; Brockman MA; Ryland EG; Dunkley-Thompson J; Steel-Duncan JC; St John MA; Conrad JA; Kalams SA; Noel F; Allen TM; Christie CD; Feeney ME
J Virol; 2009 Sep; 83(17):8616-27. PubMed ID: 19515764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
